Deregulated expression of LRBA facilitates cancer cell growth

Oncogene

Volumn 23, Issue 23, 2004, Pages 4089-4097

  Wang, Jia Wang ^a,b   Gamsby, Joshua J ^a,b   Highfill, Steven L ^a,b   Mora, Linda B ^b,c   Bloom, Gregory C ^b,d   Yeatman, Tim J ^b,d   Pan, Tien Chi ^e   Ramne, Anna L ^e   Chodosh, Lewis A ^e   Cress, W Douglas ^b,c   Chen, Jiandong ^b,c   Kerr, William G ^a,b,f  

^a Immunology Programs   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c Molecular Oncology Program   (United States)

^d Gastrointestinal Tumor Program   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f NONE   (United States)

Author keywords

E2F; Gene expression profiling; LRBA; P53; RNA interference

Indexed keywords

ENDOTHELIAL CELL GROWTH FACTOR; MESSENGER RNA; PROTEIN P53; TRANSCRIPTION FACTOR E2F1; TUMOR SUPPRESSOR PROTEIN; CARRIER PROTEIN; CELL CYCLE PROTEIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; DNA BINDING PROTEIN; E2F1 PROTEIN, HUMAN; ESTROGEN RECEPTOR; LRBA PROTEIN, HUMAN; PROTEIN P23; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F;

ARTICLE; CANCER GROWTH; CONTROLLED STUDY; DNA MICROARRAY; GENE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE MUTATION; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; LRBA GENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; BREAST TUMOR; FEMALE; GENETICS; HELA CELL; METABOLISM; MOLECULAR GENETICS; NEOPLASM; NUCLEOTIDE SEQUENCE; PHYSIOLOGY;

MAMMALIA;

BASE SEQUENCE; BREAST NEOPLASMS; CARRIER PROTEINS; CELL CYCLE PROTEINS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; FEMALE; HELA CELLS; HUMANS; MOLECULAR SEQUENCE DATA; NEOPLASMS; PROMOTER REGIONS (GENETICS); RECEPTORS, ESTROGEN; RNA INTERFERENCE; TRANSCRIPTION FACTORS;

EID: 2942535831     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207567     Document Type: Article

References (29)

1. Adam-Klages S, Adam D, Wiegmann K, Struve S, Kolanus W, Schneider-Mergener J and Kronke M. (1996). Cell, 86, 937-947.
2. Bargonetti J and Manfredi JJ. (2002). Curr. Opin. Oncol., 14, 86-91.
3. Bhattacharjee A, Richards WG, Staunton J, Li C, Monti S, Vasa P, Ladd C, Beheshti J, Bueno R, Gillette M, Loda M, Weber G, Mark EJ, Lander ES, Wong W, Johnson BE, Golub TR, Sugarbaker DJ and Meyerson M. (2001). Proc. Natl. Acad. Sci. USA, 98, 13790-13795.
4. Blomberg N, Baraldi E, Nilges M and Saraste M. (1999). Trends Biochem. Sci., 24, 441-445.
5. Bloom G, Yang IV, Boulware D, Kwong KY, Coppola D, Eschrich S, Quackenbush J and Yeatman TJ. (2004). Am. J. Pathol., 164, 9-16.
6. Dyomin V, Chaganti S, Dyomina K, Palanisamy N, Murty V, Dalla-Favera R and Chaganti R. (2002). Genomics, 80, 158.
7. Han JD, Baker NE and Rubin CS. (1997). J. Biol. Chem., 272, 26611-26619.
8. Harborth J, Elbashir SM, Bechert K, Tuschl T and Weber K. (2001). J. Cell Sci., 114, 4557-4565.
9. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW and Vogelstein B. (1998). Proc. Natl. Acad. Sci. USA, 95, 2509-2514.
10. Jogl G, Shen Y, Gebauer D, Li J, Wiegmann K, Kashkar H, Kronke M and Tong L. (2002). EMBO J., 21, 4785-4795.
11. Jorissen RN, Walker F, Pouliot N, Garrett TP, Ward CW and Burgess AW. (2003). Exp. Cell Res., 284, 31-53.
12. Kerr WG, Heller M and Herzenberg LA. (1996). Proc. Natl. Acad. Sci. USA, 93, 3947-3952.
13. Kwak E, Gerald N, Larochelle DA, Vithalani KK, Niswonger ML, Maready M and De Lozanne A. (1999). Mol. Biol. Cell, 10, 4429-4439.
14. Li D and Roberts R. (2001). Cell Mol. Life Sci., 58, 2085-2097.
15. Miller WR. (2002). Ann. NY Acad. Sci., 968, 37-48.
16. Morris C. (2002). Breast Cancer Res. Treat., 75, S51-5-S57-9 discussion.
17. Nagle DL, Karim MA, Woolf EA, Holmgren L, Bork P, Misumi DJ, McGrail SH, Dussault Jr BJ, Perou CM, Boissy RE, Duyk GM, Spritz RA and Moore KJ. (1996). Nat. Genet., 14, 307-311.
18. Ohtani K. (1999). Front Biosci., 4, D793-D804.
19. Segui B, Cuvillier O, Adam-Klages S, Garcia V, Malagarie-Cazenave S, Leveque S, Caspar-Bauguil S, Coudert J, Salvayre R, Kronke M and Levade T. (2001). J. Clin. Invest., 108, 143-151.
20. Shamloula HK, Mbogho MP, Pimentel AC, Chrzanowska-Lightowlers ZM, Hyatt V, Okano H and Venkatesh TR. (2002). Genetics, 161, 693-710.
21. Sherr CJ and McCormick F. (2002). Cancer Cell, 2, 103-112.
22. Spritz RA. (1998). J. Clin. Immunol., 18, 97-105.
23. Sui G, Soohoo C, Affar el B, Gay F, Shi Y and Forrester WC. (2002). Proc. Natl. Acad. Sci. USA, 99, 5515-5520.
24. Van Gelder RN, von Zastrow ME, Yool A, Dement WC, Barchas JD and Eberwine JH. (1990). Proc. Natl. Acad. Sci. USA, 87, 1663-1667.
25. Vogelstein B, Lane D and Levine AJ. (2000). Nature, 408, 307-310.
26. Wang JW, Howson J, Haller E and Kerr WG. (2001). J. Immunol., 166, 4586-4595.
27. Wang X, Herberg FW, Laue MM, Wullner C, Hu B, Petrasch-Parwez E and Kilimann MW. (2000). J. Neurosci., 20, 8551-8565.
28. Warrington JA, Nair A, Mahadevappa M and Tsyganskaya M. (2000). Physiol. Genomics, 2, 143-147.
29. Wiley HS. (2003). Exp. Cell. Res., 284, 78-88.